Protagonist Therapeutics Inc (PTGX)
EBITDA Margin
77.53%
Quarterly · Period ending:
PTGX EBITDA Margin
Latest reported77.53%period ending
Latest reported77.53%period ending
PTGX Quarterly EBITDA Margin (0.00% → 77.53%)
Quarterly ebitda margin
High-resolution chart · PNG
PTGX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 77.5318% | |
| 4.7687% | |
| -582.7888% | |
| -827.2071% | |
| -618.3736% | |
| -40.3093% | |
| 78.646% | |
| -705.5187% | |
| -715.5268% | |
| 82.7219% | |
| 46.945% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -4,679.1618% | |
| -78.1316% | |
| -429.2445% | |
| -321.7966% | |
| -1,333.9514% | |
| -378.0417% | |
| -322.0885% | |
| -54.4914% | |
| -280.489% | |
| -520.9761% | |
| -525.377% | |
| -383.2891% | |
| 368.5798% | |
| -854.5513% | |
| -649.5538% | |
| -151.0217% | |
| -77.6855% | |
| -75.6052% | |
| -30.101% | |
| -55.4834% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |